These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 33157099

  • 61. URB597 protects against NLRP3 inflammasome activation by inhibiting autophagy dysfunction in a rat model of chronic cerebral hypoperfusion.
    Su SH, Wu YF, Lin Q, Wang DP, Hai J.
    J Neuroinflammation; 2019 Dec 09; 16(1):260. PubMed ID: 31815636
    [Abstract] [Full Text] [Related]

  • 62. Vagus nerve stimulation as a promising neuroprotection for ischemic stroke via α7nAchR-dependent inactivation of microglial NLRP3 inflammasome.
    Xia XM, Duan Y, Wang YP, Han RX, Dong YF, Jiang SY, Zheng Y, Qiao C, Cao L, Lu X, Lu M.
    Acta Pharmacol Sin; 2024 Jul 09; 45(7):1349-1365. PubMed ID: 38504011
    [Abstract] [Full Text] [Related]

  • 63. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
    He XM, Zhou YZ, Sheng S, Li JJ, Wang GQ, Zhang F.
    Oxid Med Cell Longev; 2020 Jul 09; 2020():2963540. PubMed ID: 33294118
    [Abstract] [Full Text] [Related]

  • 64. P2X7 Receptor (P2X7R) of Microglia Mediates Neuroinflammation by Regulating (NOD)-Like Receptor Protein 3 (NLRP3) Inflammasome-Dependent Inflammation After Spinal Cord Injury.
    Fan X, Ma W, Zhang Y, Zhang L.
    Med Sci Monit; 2020 Sep 21; 26():e925491. PubMed ID: 32952148
    [Abstract] [Full Text] [Related]

  • 65. Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2/HO-1/NLRP3 pathway.
    Wang N, Nie H, Zhang Y, Han H, Wang S, Liu W, Tian K.
    Inflamm Res; 2022 Jan 21; 71(1):93-106. PubMed ID: 34767031
    [Abstract] [Full Text] [Related]

  • 66. Arctigenin attenuates ischemic stroke via SIRT1-dependent inhibition of NLRP3 inflammasome.
    Zhang S, Jiang L, Che F, Lu Y, Xie Z, Wang H.
    Biochem Biophys Res Commun; 2017 Nov 04; 493(1):821-826. PubMed ID: 28888980
    [Abstract] [Full Text] [Related]

  • 67. Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia.
    Liu Y, Dai Y, Li Q, Chen C, Chen H, Song Y, Hua F, Zhang Z.
    Neurosci Lett; 2020 Sep 25; 736():135279. PubMed ID: 32726591
    [Abstract] [Full Text] [Related]

  • 68. Sevoflurane preconditioning improves neuroinflammation in cerebral ischemia/reperfusion induced rats through ROS-NLRP3 pathway.
    Shang S, Sun F, Zhu Y, Yu J, Yu L, Shao W, Wang Z, Yi X.
    Neurosci Lett; 2023 Mar 28; 801():137164. PubMed ID: 36868396
    [Abstract] [Full Text] [Related]

  • 69. METTL3 Mediates Microglial Activation and Blood-Brain Barrier Permeability in Cerebral Ischemic Stroke by Regulating NLRP3 Inflammasomes Through m6A Methylation Modification.
    Cheng X, Ren Z, Jia H, Wang G.
    Neurotox Res; 2024 Feb 13; 42(1):15. PubMed ID: 38349604
    [Abstract] [Full Text] [Related]

  • 70. Ketone Metabolite β-Hydroxybutyrate Ameliorates Inflammation After Spinal Cord Injury by Inhibiting the NLRP3 Inflammasome.
    Kong G, Liu J, Li R, Lin J, Huang Z, Yang Z, Wu X, Huang Z, Zhu Q, Wu X.
    Neurochem Res; 2021 Feb 13; 46(2):213-229. PubMed ID: 33108630
    [Abstract] [Full Text] [Related]

  • 71. NOX2-mediated reactive oxygen species are double-edged swords in focal cerebral ischemia in mice.
    Yingze Y, Zhihong J, Tong J, Yina L, Zhi Z, Xu Z, Xiaoxing X, Lijuan G.
    J Neuroinflammation; 2022 Jul 14; 19(1):184. PubMed ID: 35836200
    [Abstract] [Full Text] [Related]

  • 72. NLRP3 Inflammasome Is Involved in Q-VD-OPH Induced Necroptosis Following Cerebral Ischemia-Reperfusion Injury.
    Teng X, Chen W, Liu Z, Feng T, Li H, Ding S, Chen Y, Zhang Y, Tang X, Geng D.
    Neurochem Res; 2018 Jun 14; 43(6):1200-1209. PubMed ID: 29802529
    [Abstract] [Full Text] [Related]

  • 73. Thiolutin attenuates ischemic stroke injury via inhibition of NLRP3 inflammasome: an in vitro and in vivo study.
    Jia Y, Xue K, Luo Y, Liu C.
    Exp Brain Res; 2023 Mar 14; 241(3):839-849. PubMed ID: 36749359
    [Abstract] [Full Text] [Related]

  • 74. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A, Wu H, Hong Y, Tu S, Sun X, Wu Q, Zhao Q, Zhang J, Sheng J.
    Mol Neurobiol; 2016 Jul 14; 53(5):3462-3476. PubMed ID: 26091790
    [Abstract] [Full Text] [Related]

  • 75. Baicalin Inhibits NLRP3 Inflammasome Activity Via the AMPK Signaling Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury.
    Zheng WX, He WQ, Zhang QR, Jia JX, Zhao S, Wu FJ, Cao XL.
    Inflammation; 2021 Oct 14; 44(5):2091-2105. PubMed ID: 34080089
    [Abstract] [Full Text] [Related]

  • 76. Dexmedetomidine exerts a protective effect on ischemic brain injury by inhibiting the P2X7R/NLRP3/Caspase-1 signaling pathway.
    Sun K, Zhang J, Yang Q, Zhu J, Zhang X, Wu K, Li Z, Xie W, Luo X.
    Brain Res Bull; 2021 Sep 14; 174():11-21. PubMed ID: 33991606
    [Abstract] [Full Text] [Related]

  • 77. ADAM8 Activates NLRP3 Inflammasome to Promote Cerebral Ischemia-Reperfusion Injury.
    Lu H, Meng Y, Han X, Zhang W.
    J Healthc Eng; 2021 Sep 14; 2021():3097432. PubMed ID: 34956566
    [Abstract] [Full Text] [Related]

  • 78. Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia.
    Huang MY, Tu CE, Wang SC, Hung YL, Su CC, Fang SH, Chen CS, Liu PL, Cheng WC, Huang YW, Li CY.
    BMC Complement Altern Med; 2018 Aug 15; 18(1):221. PubMed ID: 30107806
    [Abstract] [Full Text] [Related]

  • 79. NLRP3 Knockout Protects against Lung Injury Induced by Cerebral Ischemia-Reperfusion.
    Xu Q, Ye Y, Wang Z, Zhu H, Li Y, Wang J, Gao W, Gu L.
    Oxid Med Cell Longev; 2022 Aug 15; 2022():6260102. PubMed ID: 35432726
    [Abstract] [Full Text] [Related]

  • 80. Hirudin alleviates acute ischemic stroke by inhibiting NLRP3 inflammasome-mediated neuroinflammation: In vivo and in vitro approaches.
    Li WQ, Qin ZS, Chen S, Cheng D, Yang SC, Choi YMM, Chu B, Zhou WH, Zhang ZJ.
    Int Immunopharmacol; 2022 Sep 15; 110():108967. PubMed ID: 35724604
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.